Insider · CIK 0001014095
Fred B Craves
director
Files at MDGL (MADRIGAL PHARMACEUTICALS, INC.). First filing Nov 27, 2024, latest Mar 14, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $7.4M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MDGL: MADRIGAL PHARMACEUTICALS, INC.
MDGLOct 9, 2026 · close 471.75
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | MADRIGAL PHARMACEUTICALS, INC. | $5.1M 15,470 shares | -4% | - | |
| 53Moderate | MADRIGAL PHARMACEUTICALS, INC. | $1.1M 3,600 shares | -25% | - | |
| 53Moderate | MADRIGAL PHARMACEUTICALS, INC. | $1.2M 3,400 shares | -19% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock | +1,728 | $65.06 | $112k | 351,804 | Mar 14, 2025 |
| Mar 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock | +6,000 | $111.06 | $666k | 357,804 | Mar 14, 2025 |
| Mar 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,587 | $330.54 | $525k | 356,217 | Mar 14, 2025 |
| Mar 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -2,759 | $331.36 | $914k | 353,458 | Mar 14, 2025 |
| Mar 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -2,382 | $332.38 | $792k | 351,076 | Mar 14, 2025 |
| Mar 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -800 | $333.66 | $267k | 350,276 | Mar 14, 2025 |
| Mar 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -200 | $334.97 | $67k | 350,076 | Mar 14, 2025 |
| Mar 13, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock | +7,742 | $65.06 | $504k | 357,818 | Mar 14, 2025 |
| Mar 13, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,951 | $322.45 | $629k | 355,867 | Mar 14, 2025 |
| Mar 13, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,649 | $323.47 | $533k | 354,218 | Mar 14, 2025 |
| Mar 13, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -900 | $324.69 | $292k | 353,318 | Mar 14, 2025 |
| Mar 13, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -800 | $325.63 | $261k | 352,518 | Mar 14, 2025 |
| Mar 13, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,000 | $327.63 | $328k | 351,518 | Mar 14, 2025 |
| Mar 13, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -400 | $328.68 | $131k | 351,118 | Mar 14, 2025 |
| Mar 13, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -967 | $329.86 | $319k | 350,151 | Mar 14, 2025 |
| Mar 13, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -75 | $330.23 | $25k | 350,076 | Mar 14, 2025 |
| Mar 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -1,728 | $0.00 | $0 | 7,742 | Mar 14, 2025 |
| Mar 12, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -6,000 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 13, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -7,742 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Dec 3, 2024 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: See Footnotes | -3,080 | $315.21 | $971k | 11,520 | Dec 5, 2024 |
| Dec 3, 2024 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: See Footnotes | -520 | $315.90 | $164k | 11,000 | Dec 5, 2024 |
| Nov 25, 2024 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: See Footnotes | -2,200 | $350.08 | $770k | 15,800 | Nov 27, 2024 |
| Nov 25, 2024 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: See Footnotes | -1,200 | $350.71 | $421k | 14,600 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.